ABEL ULRICH has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1992. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are 3 DIMENSIONAL PHARMACEUTICALS INC, GENE KUTATO KFT N and CELLZOME LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers | |
#4 | Telecommunications | |
#5 | Digital networks | |
#6 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Abel Ulrich | 15 |
#2 | Feurer Achim | 6 |
#3 | Deppe Holger | 6 |
#4 | Schwarz Matthias | 3 |
#5 | Ott Inge | 3 |
#6 | Goutopoulos Andreas | 3 |
#7 | Simon Werner | 3 |
#8 | Soeberdt Michael | 2 |
#9 | Nordhoff Sonja | 2 |
#10 | Metz Guenther | 2 |
Publication | Filing date | Title |
---|---|---|
WO2008071682A2 | Non-randomness in the clustering or genomic events detects insertional mutagenesis in clinical gene therapy |